Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aligos Therapeutics (ALGS) Return on Assets (2021 - 2025)

Aligos Therapeutics (ALGS) has disclosed Return on Assets for 5 consecutive years, with 0.24% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 141.0% year-over-year to 0.24%, compared with a TTM value of 0.24% through Dec 2025, up 141.0%, and an annual FY2025 reading of 0.31%, up 88.0% over the prior year.
  • Return on Assets was 0.24% for Q4 2025 at Aligos Therapeutics, up from 0.71% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.24% in Q4 2025 and bottomed at 1.66% in Q4 2024.
  • Average Return on Assets over 5 years is 0.69%, with a median of 0.64% recorded in 2022.
  • The sharpest move saw Return on Assets tumbled -92bps in 2024, then skyrocketed 141bps in 2025.
  • Year by year, Return on Assets stood at 0.51% in 2021, then dropped by -20bps to 0.62% in 2022, then decreased by -20bps to 0.74% in 2023, then tumbled by -124bps to 1.66% in 2024, then surged by 85bps to 0.24% in 2025.
  • Business Quant data shows Return on Assets for ALGS at 0.24% in Q4 2025, 0.71% in Q3 2025, and 0.52% in Q2 2025.